
Cybersight
Medical
Free · Designed for iPad
Cybersight is an online community for eye health professionals in developing countries.
All Cybersight services are free of charge.
EXPERT ADVICE
Get expert advice and a second opinion for your patient cases. More than 100 international expert mentors are ready to help.
WORKS OFFLINE
Create, view and respond to cases without an internet connection. Your data syncs automatically when your connection resumes.
GROW YOUR KNOWLEDGE
Learn from thousands of unique cases from ophthalmology colleagues around the world. Search by location or diagnosis.
ARTIFICIAL INTELLIGENCE
Use our AI technology to detect eye diseases like diabetic retinopathy, glaucoma and macular disease from uploaded fundus images.
ONLINE COURSES
The app provides seamless access to Cybersight Courses.
Log in with your existing Cybersight account or join the community using the app.
Ratings & Reviews
Minor bug fixes and performance improvements
The developer, Project ORBIS International Inc, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Linked to You
The following data may be collected and linked to your identity:
- Location
- Contact Info
- User Content
- Identifiers
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Usage Data
- Diagnostics
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Project ORBIS International Inc
- Size
- 52.1 MB
- Category
- Medical
- Compatibility
Requires iOS 13.0 or later.
- iPhone
Requires iOS 13.0 or later. - iPad
Requires iPadOS 13.0 or later. - iPod touch
Requires iOS 13.0 or later. - Mac
Requires macOS 12.0 or later and a Mac with Apple M1 chip or later. - Apple Vision
Requires visionOS 1.0 or later.
- Languages
- English
- Age Rating
16+
- 16+
- Frequent
Medical Treatment information
- Copyright
- © 2025 Project Orbis International, Inc.